Literature DB >> 27270138

Sexually acquired hepatitis C virus infection: a review.

Denise P C Chan1, Hsin-Yun Sun2, Horas T H Wong3, Shui-Shan Lee1, Chien-Ching Hung4.   

Abstract

Sexually acquired hepatitis C virus (HCV) infection remains a public health problem, with significant disease burden primarily in HIV-positive men who have sex with men (MSM). Over the past decades, the epidemic of sexually transmitted HCV infection has continued to expand and the epidemiology of HCV in HIV has changed significantly. In the post-combination antiretroviral therapy era, sexual network characteristics within the specific core group of MSM with increased sexual risk behaviours, including serosorting on the basis of HIV-positive status and intense mucosally traumatic sexual practices, confer increased HCV acquisition and transmission. This review summarizes the current epidemiology of sexually acquired HCV infection and the clinical and immunological contexts of acute HCV infection, and describes the biological, social, and behavioural factors that have facilitated permucosal transmission of HCV in MSM. While the advent of direct-acting antivirals has improved treatment responses significantly, sexually transmitted HCV reinfections occur in a substantial proportion of HIV-positive MSM following clearance of a primary infection. Effective strategies and preventive interventions that are tailored to the MSM communities to facilitate the control of sexually acquired HCV infection cannot be overemphasized.
Copyright © 2016 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Combination antiretroviral therapy; Direct-acting antivirals; Men who have sex with men; Sex health; Sex network; Sexually transmitted infection; Viral hepatitis

Mesh:

Year:  2016        PMID: 27270138     DOI: 10.1016/j.ijid.2016.05.030

Source DB:  PubMed          Journal:  Int J Infect Dis        ISSN: 1201-9712            Impact factor:   3.623


  36 in total

1.  Oligonucleotide-Lipid Conjugates Forming G-Quadruplex Structures Are Potent and Pangenotypic Hepatitis C Virus Entry Inhibitors In Vitro and Ex Vivo.

Authors:  George Koutsoudakis; Alexia Paris de León; Carolina Herrera; Marcus Dorner; Gemma Pérez-Vilaró; Sébastien Lyonnais; Santiago Grijalvo; Ramon Eritja; Andreas Meyerhans; Gilles Mirambeau; Juana Díez
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

2.  Prevalence and Phylogenetic Characterization of Hepatitis C Virus Among Indian Men Who Have Sex With Men: Limited Evidence for Sexual Transmission.

Authors:  Steven J Clipman; Priya Duggal; Aylur K Srikrishnan; Shanmugam Saravanan; Pachamuthu Balakrishnan; Canjeevaran K Vasudevan; David D Celentano; David L Thomas; Shruti H Mehta; Sunil S Solomon
Journal:  J Infect Dis       Date:  2020-05-11       Impact factor: 5.226

3.  Years of life lost to cancer among the United States HIV population, 2006-2015.

Authors:  Qianlai Luo; Ruth M Pfeiffer; Anne-Michelle Noone; Marie-Josèphe Horner; Eric A Engels; Meredith S Shiels
Journal:  AIDS       Date:  2022-05-25       Impact factor: 4.632

4.  Risk factors for HCV transmission in HIV-positive men who have sex with men in México.

Authors:  José Antonio Mata-Marín; Armando Abraham de Pablos-Leal; Stefan Mauss; Carla Ileana Arroyo-Anduiza; Mara Soraya Rodríguez-Evaristo; Luis Antonio Uribe-Noguéz; María de Los Ángeles Berrospe-Silva; Juan Carlos Lara-Castañeda; Edgar Pérez-Barragán; Jesús Gaytán-Martínez
Journal:  PLoS One       Date:  2022-07-15       Impact factor: 3.752

5.  Performance of Hepatitis C Virus (HCV) Core Antigen Assay in the Diagnosis of Recently Acquired HCV Infection among High-Risk Populations.

Authors:  Hsin-Yun Sun; Wang-Da Liu; Chih-Wen Wang; Yu-Ju Wei; Kuan-Yin Lin; Yu-Shan Huang; Li-Hsin Su; Yi-Ting Chen; Wen-Chun Liu; Yi-Chin Su; Yea-Wen Chen; Yu-Chung Chuang; Po-Liang Lu; Chien-Ching Hung; Ming-Lung Yu
Journal:  Microbiol Spectr       Date:  2022-05-17

6.  Are we on the precipice of a new epidemic? Risk for hepatitis C among HIV-negative men-, trans women-, and trans men- who have sex with men in the United States.

Authors:  Christian Grov; Drew A Westmoreland; Adam W Carrico; Denis Nash
Journal:  AIDS Care       Date:  2020-03-15

Review 7.  Tumour virus epidemiology.

Authors:  Ruth M Lunn; Gloria D Jahnke; Charles S Rabkin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

8.  High prevalence of unawareness of HCV infection status among both HCV-seronegative and seropositive people living with human immunodeficiency virus in Taiwan.

Authors:  Chun-Yuan Lee; Pei-Hua Wu; Meng-Wei Lu; Tun-Chieh Chen; Po-Liang Lu
Journal:  PLoS One       Date:  2021-05-06       Impact factor: 3.240

9.  Real-World Experience with Coformulated Ledipasvir and Sofosbuvir for HIV-Positive Patients with HCV Genotype 2 Infection: A Multicenter, Retrospective Study.

Authors:  Bo-Huang Liou; Hsin-Yun Sun; Chia-Jui Yang; Ling-Shan Syue; Yu-Lin Lee; Hung-Jen Tang; Hung-Chin Tsai; Chi-Ying Lin; Tun-Chieh Chen; Chun-Yuan Lee; Sung-Hsi Huang; Chia-Wei Liu; Po-Liang Lu; Shih-Ping Lin; Ning-Chi Wang; Aristine Cheng; Wen-Chien Ko; Shu-Hsing Cheng; Chien-Ching Hung
Journal:  Infect Dis Ther       Date:  2021-03-18

Review 10.  Transplanting Organs from Donors with HIV or Hepatitis C: The Viral Frontier.

Authors:  Brian J Boyarsky; Alexandra T Strauss; Dorry L Segev
Journal:  World J Surg       Date:  2021-01-20       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.